https://thyroidworldcongress.com/wp-content/uploads/wctc4-banner.jpg

March 13 Product Theatres


  • 9:45 am – Fluoptics
  • 12:00 noon – Loxo Oncology at Lilly
9:45 am – Fluoptics

The Initial Experience of Fluobeam at Harvard

This product theater is dedicated to the presentation of the initial experience of the FLUOBEAM®LX by Prof. Greg Randolph at Harvard.

The System has been utilized at the MEEI since October 2020 and Prof. Randolph and his team have performed 75 cases with the FLUOBEAM®LX

Prof. Randolph will describe how he approaches the use of autofluorescence imaging and how this technique impacts his surgery. He will detail the learning of the product providing tips and tricks and will go more in detail on how he uses it today in his thyroidectomies (and parathyroidectomies).

This session will illustrate:

– The system’s ability to detect parathyroid prior to visual identification during surgery
– The system’s use in interrogation of the resected thyroid specimen
– World class panel will discuss implementation and value of FLUOBEAM®LX

12:00 noon – Loxo Oncology at Lilly

Retevmo® (selpercatinib) program presented by Dr. Bryan McIver

This program is sponsored by and the speaker is presenting on behalf of Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.

Retevmo® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
© Lilly USA, LLC 2020. All rights reserved.

Program Description

Join us to review the clinical data for LIBRETTO-001, examine the efficacy and safety profiles, and explore the dosing, dose modifications, administration, and appropriate testing methods for a biomarker-driven therapy. This program aims to help you identify patients who may be eligible for this treatment option.


Back to Sponsorship
Sponsorship Opportunities

There are outstanding opportunities for industry participation. For more details on the available sponsorship and exhibitor options, please contact:


Rebecca Darling, rebecca@bayleygroup.com
Call: +1. 519.263.5050 / +1. 519.263.6001 (direct)
Toll Free: 1.888.527.3434
(North America only)
Cass Bayley cass@bayleygroup.com
Call: +1. 519.263.5050 / +1. 519.263.6000 (direct)
Toll Free: 1.888.527.3434
(North America only)

Keep in Touch with Us

Join our mailing list to receive the latest updates and get the first look at new content.
© 2021 World Congress on Thyroid Cancer Privacy Policy
Share via
Copy link
Powered by Social Snap